Referenced MDPDA clinical resources in Oncology, with transparent evidence and review metadata.
An evidence-informed international clinical reference on superior vena cava obstruction, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on tumour lysis syndrome, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on immune checkpoint inhibitor toxicity, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on chemotherapy-induced nausea and vomiting, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on colorectal cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on pancreatic cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on ovarian cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on endometrial cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on cervical cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on head and neck squamous cell carcinoma, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on melanoma systemic therapy, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on cancer-associated venous thromboembolism, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on malignant spinal cord compression, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on breast cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on early prostate cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on metastatic prostate cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on non-small-cell lung cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
An evidence-informed international clinical reference on small-cell lung cancer, for healthcare professionals across the UK, US, Canada, Australia, New Zealand and Ireland. It covers recognition, assessment, management, escalation, follow-up and jurisdiction-sensitive practice considerations.
